The determination of these parameters in our metabolic syndrome model showed only a slight increase in the ALT level that was not observed in the HF+IFC-305 group, and there was no difference in the AST level in the experimental groups, suggesting a protective effect against the accumulation of fat in the liver. This evidence concerns the gene GPT and metabolic syndrome.